Clinical Trial Results:
A Randomized, Global, Open-label Study of Nivolumab in Combination with BMS-986205 vs Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck
Summary
|
|
EudraCT number |
2017-003059-46 |
Trial protocol |
BE CZ ES |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
29 Jul 2021
|
First version publication date |
29 Jul 2021
|
Other versions |
|
Summary report(s) |
2017-003059-46_CA017-063 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.